New syringe could make eye injections easier for macular degeneration patients

NCT ID NCT07214740

Completed Disease control Sponsor: Apellis Pharmaceuticals, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a drug called pegcetacoplan, given as an eye injection using a prefilled syringe, in 44 people with geographic atrophy (a form of advanced age-related macular degeneration). The main goal was to see if the new syringe is safe and easy for doctors to use. The drug aims to slow the growth of blind spots in the center of vision.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Pegcetacoplan (a drug that targets part of the immune system to slow eye damage)
What this could lead to: If successful, this could provide a more convenient way to deliver pegcetacoplan, potentially slowing vision loss from geographic atrophy.
What could go wrong: This is a small, single-arm study focused on safety, not effectiveness. The drug may not work for everyone, and eye injections carry risks like infection or inflammation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

age-related macular degeneration Geographic Atrophy macular degeneration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION

Contacts and locations

Locations

Austin Retina Associates

Austin, Texas, 78705, United States
California Retina Consultants

Bakersfield, California, 93309, United States
California Retina Consultants

Oxnard, California, 93036, United States
Retina Consultants of Texas

Katy, Texas, 77494, United States
Retina Consultants of Texas

Woodland, Texas, 77384, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.